These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3257903)

  • 1. Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens.
    Romani L; Grohmann U; Fazioli F; Puccetti P; Mage MG; Fioretti MC
    Cancer Immunol Immunother; 1988; 26(1):48-54. PubMed ID: 3257903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo.
    Romani L; Puccetti P; Fioretti MC; Mage MG
    Int J Cancer; 1985 Aug; 36(2):225-31. PubMed ID: 3894248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens.
    Grohmann U; Puccetti P; Fioretti MC; Mage MG; Romani L
    Int J Immunopharmacol; 1988; 10(7):803-9. PubMed ID: 3266198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells.
    Romani L; Grohmann U; Puccetti P; Rossi MA; Fioretti MC
    Int J Immunopharmacol; 1990; 12(7):743-9. PubMed ID: 2292454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variation in cancer metastasis: immune escape versus immune control.
    Schirrmacher V; Fogel M; Russmann E; Bosslet K; Altevogt P; Beck L
    Cancer Metastasis Rev; 1982; 1(3):241-74. PubMed ID: 6985248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes.
    D'Atri S; Romani L; Bonmassar E; Grohmann U; Tricarico M; Christmas SE; Moore M
    Int J Immunopharmacol; 1994 Jul; 16(7):569-79. PubMed ID: 7928005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant.
    Ding LN; Yoshida T; Isobe K; Rahman SM; Nagase F; Yokochi T; Kawashima K; Nakashima I
    Jpn J Cancer Res; 1991 Jul; 82(7):841-7. PubMed ID: 1679057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization.
    Puccetti P; Bianchi R; Romani L; Cenci E; Fioretti MC
    Int J Cancer; 1989 Feb; 43(2):279-84. PubMed ID: 2465277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
    Romani L; Fioretti MC; Bonmassar E
    Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotides.
    Grohmann U; Binaglia L; Puccetti P; Fioretti MC
    Int J Immunopharmacol; 1993 Jul; 15(5):567-72. PubMed ID: 8375938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells.
    von Hoegen P; Altevogt P; Schirrmacher V
    Cell Immunol; 1987 Oct; 109(2):338-48. PubMed ID: 3117377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells.
    Romani L; Puccetti P; Grohmann U; Cenci E; Mage MG; Fioretti MC
    Int J Immunopharmacol; 1989; 11(5):537-42. PubMed ID: 2807629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
    Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
    Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo.
    Taramelli D; Romani L; Bonmassar A; Goldin A; Fioretti MC
    Eur J Cancer (1965); 1981 Apr; 17(4):411-20. PubMed ID: 6171429
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of protective and cytotoxic immune responses in vivo against metabolically inactivated and untreated cells of a mutagenized tumor line (requirements for tumor immunogenicity).
    Wehrmaker A; Lehmann V; Dröge W
    Cell Immunol; 1986 Sep; 101(2):290-8. PubMed ID: 2428514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L
    Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant.
    Romani L; Grohmann U; Puccetti P; Nardelli B; Mage MG; Fioretti MC
    Cell Immunol; 1988 Feb; 111(2):365-78. PubMed ID: 3123072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.
    Marelli O; Franco P; Canti G; Ricci L; Prandoni N; Nicolin A; Festenstein H
    Br J Cancer; 1988 Aug; 58(2):171-5. PubMed ID: 2458749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.